Partners 2026

National Lab partner

PureLab, a PureHealth asset, operates and manages the largest network of laboratories in the region; these also include the largest network of ISO Accredited Laboratories currently totalling over 160+ labs across the UAE. PureLab, is a comprehensive laboratory operation that supports both the public and private sectors by providing the largest in-house test menu. PureLab leverages economies of scale with our high volume of tests (over 25 million tests conducted per year) and runs an agile operation that ensures accurate, reliable, and timely diagnostics, delivered to our customers. The company also plays a pivotal role in using its laboratory diagnostics network to conduct public screening programmes and population health management, as well as spearheading COVID-19 screening efforts in the UAE. Bringing in unparalleled efficiencies and redefining industry standards, PureLab has proven itself as a partner of choice.

Innovation partner

Since its establishment in 1995, Snibe has contributed to the development of the IVD field through Chemiluminescence immunoassay products. Focusing on Chemiluminescence immunoassay solutions over 28 years, Snibe’s total installations currently reach 23,900 units, with products exported to more than 150 countries globally. At present, Snibe has 3 main product lines: Immunoassay, Clinical chemistry and Molecular diagnosis, providing diversified total laboratory automation solutions. Meanwhile, Snibe’s Auto-immunoassay analyzer Maglumi X8 has the fastest throughput which can reach up to 600 tests per hour. Snibe also owns a broad CLIA test menu of up to 194 parameters, as well as a fully automated production line with an annual productivity of 4 million reagent kits. Outstanding product quality is inseparable from the support of brilliant talents. In pursuing the best quality and best service, Snibe has established a Reagents R&D and Production center, Instruments R&D and Production center, and Sales & Marketing center to form a strong team of professionals, among which professional R&D personnel accounts for more than 16%. To be the pioneer in the global diagnosis field is Snibe's vision. Their strive for excellence never ends.

Smart Lab partner

Sysmex supports healthcare professionals and patients around the world with a broad range of medical diagnostics products and solutions. With over 50 years’ experience in in-vitro diagnostics and beyond, we are continuously developing our product and service portfolio to cover the entire patient pathway of care. Our multi-functional solutions work together with high-quality reagents and reliable service to create a better healthcare journey for all. Sysmex Middle East FZ-LLC is a subsidiary of Sysmex Europe SE in Hamburg, Germany. Established in April 2008 as a regional hub for Sysmex activities throughout Middle Eastern countries. Since its formation, Sysmex Middle East has developed strong, lasting relationships with healthcare professionals through demonstrated excellence in high-level training, service and support. Its value-enhancing services provide customers with a personalised, tailored approach, delivering anything from standalone diagnostic solutions to fully integrated managed service agreements.

Abbott is a global healthcare leader that helps people live more fully at all stages of life.

Their portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Abbott's 113,000 colleagues serve people in more than 160 countries.

A global leader in clinical diagnostics, Beckman Coulter Diagnostics has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. The company’s mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and this is done by applying the power of science, technology and the passion and creativity of their teams. The company’s diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. They exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. This is done by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, California, with more than 11,000 global team members.

Beckman Coulter Diagnostics is proud to be part of Danaher. Danaher’s science and technology leadership puts Beckman Coulter Diagnostics’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means Beckman Coulter Diagnostics can offer unparalleled breadth and depth of expertise and solutions to their customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, Beckman Coulter Diagnostics unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (systems, reagents, software and services) that determine the origin of a disease to improve the health of patients.

World leader in microbiology, specialized in immunoassays and leading pioneer in the syndromic molecular approach, the company is committed worldwide on major public health issues in the field of infectious diseases, such as antimicrobial resistance, sepsis and respiratory infections.

Established in 1982, Randox is dedicated to improving healthcare worldwide through the use of innovative diagnostic technologies. As experts in clinical chemistry, their product offering is designed to make the diagnostic process faster, more accurate and cost effective. The Randox portfolio comprises diagnostic reagents including many unique reagents, third party quality controls, the world’s largest EQA scheme and clinical chemistry analysers.

The patented Randox Biochip Technology and associated Immunoassay analysers allow simultaneous screening of multiple targets, improving the diagnostic power available to clinicians. Novel biochips are available for diagnosis of stroke, Alzheimer’s disease, bladder cancer, prostate cancer, AKI and gastrointestinal diseases, allowing earlier diagnosis and timely intervention. Additional applications include routine immunoassay testing, molecular diagnostics, forensic toxicology and food diagnostics. As a world leader in diagnostics for over 40 years, Randox's expertise and product portfolio have assisted laboratories across the world in improving health and saving lives.

Siemens Healthineers is a leading medtech company with over 125 years of experience. The company's portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways.

With Siemens Healthineers'' strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), they are well-positioned to take on the biggest challenges in healthcare. Siemens Healthineers will continue to build on these strengths to help fight the world’s most threatening diseases, improving the quality of outcomes, and enabling access to care. The company are a team of 66,000 highly dedicated employees across more than 70 countries passionately pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

BIOBASE is a high-tech enterprise whose business covers biomedical, e-commerce, intelligent manufacturing, scientific equipment, In Vitro Diagnosis (IVD) instruments and reagents.

With more than 5,000 people and 31 workshops, covering a total area of 932,900 m2, BIOBASE has established companies in the USA, UAE, India, Algeria, Singapore, Myanmar and other countries. BIOBASE is specialized in medical equipment and laboratory equipment products, with more than 200 existing high-tech products.

Since 1993 the DNA-Technology Group has been developing, producing and introducing high-tech equipment and reagents for PCR analysis. The company's products are supplied to hospitals and laboratories through a global distribution network in more than 45 countries all over the world.

Their goal is to apply the latest scientific discoveries in the field of molecular biology methods to routine laboratory practice to improve diagnostic quality for effective treatment and the prognosis of clinical outcome more precise. The company is certified in accordance with ISO 13485:2016, ISO 9001:2015. The manufactured products conform regulatory requirements for IVD Medical Devices (Directive 98/79/EC) and CE IVD certified.

Erba Mannheim is a global leader in in-vitro diagnostics, dedicated to delivering innovative, affordable, and reliable diagnostic solutions to laboratories worldwide.

With a strong presence in over 100 countries, Erba offers a comprehensive portfolio of clinical chemistry, hematology, immunology, and molecular diagnostics systems, tailored to meet the diverse needs of healthcare providers. The company's mission is to empower healthcare professionals with high-quality diagnostic tools that enhance patient outcomes and improve healthcare accessibility across emerging and developed markets.

Mindray is a leading global designer, developer, and manufacturer of medical devices and solutions, dedicated to making better healthcare more accessible to humanity. Since its foundation in 1991, Mindray has been exclusively focused on the medical industry in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging.

Headquartered in Shenzhen China, Mindray is a multinational corporation with subsidiaries in almost 40 countries in North and South America, Europe, Africa, and the Asia-Pacific region. Its products and services are available in over 190 countries.

QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins.

The company delivers Sample to Insight solutions for molecular testing, propelling customers from start to finish to unlock new insights. This is how QIAGEN makes improvements in life possible.

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence. Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us. QuidelOrtho is advancing diagnostics to power a healthier future.

FL Medical is an Italian leading laboratory equipment manufacturer that has been producing laboratory products for medical technology since 1979.

They have been successful year after year by manufacturing medical laboratory equipment constantly improved through hard work. FL Medical offers customers not only high-quality medical lab equipment but experience, professionalism and the broadest guarantees, too.

In 2014, Fujifilm established “Value from Innovation” as our corporate slogan, declaring our company‘s commitment to continue producing innovative new technologies, products and services. In line with the slogan, in 2018 we launched a new global branding campaign entitled NEVER STOP highlighting Fujifilm‘s commitment to providing new value through innovative advanced technologies, contributing to the solution of various issues facing society, while also declaring a commitment to NEVER STOP producing value through innovation, a strong statement of Fujifilm‘s ambition and approach which this campaign will communicate to people around the world. Our message is clear.

For more than 80 years, we‘ve continued to transform ourselves. Building from our origins as a photographic film, we evolved into a technology company working in areas such as healthcare, highly functional materials, imaging solutions, document solutions and more. In healthcare, Fujifilm is engaged in prevention, diagnosis, and treatment. We are pioneering the world of biopharmaceuticals and regenerative medicine, while also developing revolutionary healthcare IT, allowing medical professionals to make more precise diagnoses more quickly. By leveraging our advanced and unique technologies, we will continue creating value from innovation and contribute to solving social challenges. This means we‘ll never stop building on our experience and expertise to help transform ourselves, and the world.

Founded in 1953, HORIBA has explored a wide range of unique measurement and analysis technologies to meet global customer needs from group companies and local sites spread across 29 counties and regions. Under the corporate motto Joy and Fun, the company has expanded and refined its core technologies to solve society’s energy issues of today and tomorrow.

Their unique measurement and analysis technologies are valued in various fields of society including the three megatrend business fields of Energy & Environment, Biology & Healthcare and Materials & Semiconductor.

MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI) is committed to building core tools and technologies that drive innovation in life science. The company's focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. MGI provides real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries.

Founded in 2016, MGI has emerged as a global leader, operating on six continents with facilities for research, manufacturing, training, and after-sales service. Notably, MGI is among the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with diverse throughput capacities. As of June 30, 2024, MGI employs over 2,670 people, with approximately 32.16% in research and development. Operating in over 100 countries, MGI serves more than 3,000 users, showcasing its commitment to shaping the future of life sciences.

Seegene is a global leader in biotechnology, based in South Korea, with seven international subsidiaries, including one in the UAE. Seegene specializes in molecular diagnostic solutions, particularly in the development of high multiplex PCR technology.

Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity. Seegene has produced and delivered molecular diagnostics (MDx) products capable of detecting multiple targets simultaneously. Seegene’s high multiplex assays deliver comprehensive clinical information in a single test and allow accurate and rapid diagnosis.